medigraphic.com
Federación Mexicana de Ginecología y Obstetricia, A.C.

2017, Number 10

<< Back Next >>

Ginecol Obstet Mex 2017; 85 (10)

Controversies in the management of peritoneal strumosis: Case report and literature review.

Díaz-Rabasa B, Agustín-Oliva A, Laborda-Gotor RA, Tobías-González P, Negredo-Quintana I, Lanzón-Laga A, Ruiz-Conde MA

Language: Spanish
References: 22
Page: 705-710
PDF size: 389.64 Kb.


ABSTRACT

Background: Struma ovarii is a highly specialized monodermic teratoma composed of thyroid tissue in more than 50%. An infrequent form of presentation is peritoneal strumosis, which consists of multiple peritoneal implants of benign mature thyroid tissue. In both situations, there is no consensus about the management of those entities. In addition, malignancy of peritoneal strumosis is controversial.
Clinical case: We report a case of a 33-year-old nulligravid woman that during a sterility study was diagnosed with a right struma ovarii. Three years after treatment, it recurred as a left struma ovarii and a peritoneal strumosis (intraoperative finding). A laparoscopic ovarian cystectomy was performed in both cases, as well as the excision of all macroscopic implants in the second one. She remained in remission after 131I ablative chemotherapy (100 mCi), but a new recurrence took place four years later, requiring a cytoreductive surgery and a second 131I chemotherapy (100 mCi). She is now in complete remission.
Conclusions: Due to the lack of casuistry of struma ovarii and paucity of information, especially in the case of peritoneal strumosis, decisions must be individualized on each patient and must be taken by a multidisciplinary team. Cytoreductive surgery might be an option to improve the response to ablative 131I chemotherapy.


REFERENCES

  1. Dardik RB, Dardik M, Westra W, Montz FJ. Malignant struma ovarii: two case reports and a review of the literature. Gynecol Oncol 1999;73(3):447-51.

  2. Ferrero A, Fernández-González C, Fernández-Corona A, Salas JS, Carriles R, Hernández-Rodríguez JL. Struma ovarii: un tumor ovárico infrecuente. Clínica e Investigación en Ginecología y Obstetricia 2003;30(08):270-2.

  3. Yoo S-C, Chang K-H, Lyu M-O, Chang S-J, Ryu H-S, Kim H-S. Clinical characteristics of struma ovarii. J Gynecol Oncol 2008;19(2):135-8.

  4. Labiano T, Echeveste JI, Idoate MA, Bondía JM, Lozano MD. Struma ovarii maligno no sospechado: diagnóstico citológico mediante punción aspirativa con aguja fina de lesión vertebral metastásica. Rev Esp Patol 2012;45(4):238-42.

  5. Shaco-Levy R, Bean SM, Bentley RC, Robboy SJ. Natural history of biologically malignant struma ovarii: analysis of 27 cases with extraovarian spread. Int J Gynecol Pathol 2010;29(3):212-27.

  6. Devaney K, Snyder R, Norris HJ, Tavassoli FA. Proliferative and histologically malignant struma ovarii: a clinicopathologic study of 54 cases. Int J Gynecol Pathol 1993;12(4):333-43.

  7. Kim D, Cho H-C, Park J-W, Lee W-A, Kim Y-M, Chung P-S, et al. Struma ovarii and peritoneal strumosis with thyrotoxicosis. Thyroid 2009;19(3):305-8.

  8. Marti JL, Clark VE, Harper H, Chhieng DC, Sosa JA, Roman SA. Optimal surgical management of well-differentiated thyroid cancer arising in struma ovarii: a series of 4 patients and a review of 53 reported cases. Thyroid 2012;22(4):400-6.

  9. Roth LM, Karseladze AI. Highly differentiated follicular carcinoma arising from struma ovarii: a report of 3 cases, a review of the literature, and a reassessment of so-called peritoneal strumosis. Int J Gynecol Pathol 2008;27(2):213-22.

  10. Hwu D, Tsai S, Chan H, Chen Y, Chen Y, Hsiao P. A rare case of histologic benign struma ovarii with distant metastasis. J Clin Gynecol Obstet 2014;3(3):108-13.

  11. González Aguilera B, Guerrero Vázquez R, Gros Herguido N, Sánchez Gallego F, Navarro González E. The lack of consensus in management of malignant struma ovarii. Gynecol Endocrinol 2015;31(4):258-9.

  12. Balasch J, Pahisa J, Márquez M, Ordi J, Fábregues F, Puerto B, et al. Metastatic ovarian strumosis in an in-vitro fertilization patient. Hum Reprod 1993;8(12):2075-7.

  13. Zhang X, Axiotis C. Thyroid-Type Carcinoma of Struma Ovarii. Arch Pathol Lab Med 2010;134(5):786-91.

  14. Ranade R, Rachh S, Basu S. Late Manifestation of Struma Peritonei and Widespread Functioning Lesions in the Setting of Struma Ovarii Simulating Highly Differentiated Follicular Carcinoma. J Nucl Med Technol 2015;43(3):231-3.

  15. Navarro P, López L, González M, Sangrós M, Liévano P, Álvarez S, et al. Peritoneal strumosis: An extension study with 99mTc-pertechnetate. Rev Esp Med Nucl E Imagen Mol 2012;31(2):97-100.

  16. Brogsitter C, Wonsak A, Würl K, Kotzerke J. Peritoneal strumosis. Eur J Nucl Med Mol Imaging 2004;31(7):1057.

  17. Wee JYS, Li X, Chern BSM, Chua ISY. Struma ovarii: management and follow-up of a rare ovarian tumour. Singapore Med J 2015;56(1):35-9.

  18. Nezhat FR, DeNoble SM, Liu CS, Cho JE, Brown DN, Chuang L, et al. The Safety and Efficacy of Laparoscopic Surgical Staging and Debulking of Apparent Advanced Stage Ovarian, Fallopian Tube, and Primary Peritoneal Cancers. JSLS 2010;14(2):155-68.

  19. Wolff EF, Hughes M, Merino MJ, Reynolds JC, Davis JL, Cochran CS, et al. Expression of Benign and Malignant Thyroid Tissue in Ovarian Teratomas and the Importance of Multimodal Management as Illustrated by a BRAFPositive Follicular Variant of Papillary Thyroid Cancer. Thyroid 2010;20(9):981-7.

  20. Goffredo P, Sawka AM, Pura J, Adam MA, Roman SA, Sosa JA. Malignant struma ovarii: a population-level analysis of a large series of 68 patients. Thyroid 2015;25(2):211-5.

  21. Karseladze AI, Kulinitch SI. Peritoneal strumosis. Pathol Res Pract 1994;190(11):1082-1085.

  22. Baena-Del Valle J, Gutiérrez-Sanmartín J, Redondo-De Oro K, Redondo-Bermúdez C. Estrumosis peritoneal: reporte de caso y revisión de la literatura. Rev Colomb Obstet Ginecol 2011;62(4):326-30.




2020     |     www.medigraphic.com